K+S

We enrich life for generations

The products and services of K+S are crucial for supplying the population in the fields of medicine, pharmaceuticals, food production, agriculture and animal feed. By using our underground caverns, we also contribute to an orderly waste management system.

Press release of December 23, 2021

Werra-Fulda potash district: Authority grants discharge permit until the end of 2027

By granting the permit under water law today, the Kassel Regional Council has provided further security for the production of mineral fertilizers and high-purity salt products at the K+S Werra and Neuhof-Ellers sites. The previous permit expires at the end of the year.

To the press release

Press release of December 22, 2021

Closing completed: Merger into REKS joint venture concluded

Today, K+S and REMEX successfully completed the transaction for the new REKS joint venture. The joint venture will operate under the name REKS GmbH & Co. KG.

To the press release

Press release of December 15, 2021

Environmentally friendly and sustainable mining

K+S is committed to complying with the principles for sustainable extraction and processing of raw materials formulated by the EU (“EU principles for sustainable raw materials”). These principles essentially concern social, ecological, and economic aspects as well as sustainable corporate governance.

To the press release

Press release of December 1, 2021

German Federal Cartel Office grants clearance: REKS joint venture approved – higher EBITDA expected for 2021

The German Federal Cartel Office has granted the final approval for the merger of the new REKS joint venture. With this joint venture, K+S and REMEX, a subsidiary of the REMONDIS Group, aim to open up the attractive and rapidly growing European market for the recovery and disposal of waste as well as the realization of sustainable waste management solutions.

To the press release

Press release of November 25, 2021

FREP proceedings: Final examination findings do not sustain material preliminary findings and do not result in adjustments to valuations

The German Financial Reporting Enforcement Panel (FREP - “DPR”) today issued its final examination findings. These do not sustain significant preliminary findings and do not result in adjustments to valuations.

To the press release

Focus on potash and magnesium

In the future, K+S will place its strategic focus on its core business with potash and magnesium products. In doing so, we are keeping a firm eye on the environment, nature and climate protection. Every entrepreneurial decision must be in line with our climate strategy. In this way, we also ensure broad social acceptance of our actions.

New Strategy

Q3/2021 Quarterly Report

Positive outlook for the rest of the year

In this interview, Dr. Burkhard Lohr, Chairman of the Board of Executive Directors of K+S AG, explains the Company's operating performance in the third quarter of 2021, talks about the 2021 outlook and the new corporate strategy.

Strong third quarter in 2021

Significant increase in earnings – forecast raised

In the third quarter, K+S again increased revenues and operating earnings very significantly year-on-year. The forecast for 2021 was increased again. 

To the press release

Ad hoc disclosure of October 26, 2021

Forecast K+S Aktiengesellschaft

K+S raises operating EBITDA outlook for 2021 again to around EUR 630 million (previously: EUR 500 to 600 million; excluding REKS transaction)
Balanced free cash flow expected for 2021 (previously: EUR -180 million; excluding REKS transaction)
Antitrust review of REKS transaction still ongoing

To the ad hoc disclosure

Annual Report 2020

Read all numbers and facts about K+S in our new 2020 Annual Report.

Difficult conditions: The declined EBITDA from continuing and discontinued operations in 2020 (2019: €640 million) was mainly attributable to lower potash prices, a weaker de-icing salt business due to weather conditions, corona, and one-off expenses associated with the restructuring of the administrative functions.

Get more details

K+S pharmaceutical salt (APISAL®) is produced by a highly developed evaporated salt process and contains no additives.

Transportation medium for the corona vaccine

The Biontech/Pfizer corona vaccine COMIRNATY® is only applicable with the addition of high-purity sodium chloride solution. K+S is one of the largest manufacturers of the pharmaceutical-grade sodium chloride required for this purpose.

To the press release

Dealing with the corona pandemic

It is part of our social responsibility to serve the needs of our customers in the medical, pharmaceutical, food production, animal feed and agricultural sectors in the best possible way and to ensure the safe disposal of waste.

Digitalization in Africa’s agriculture

Together with local partners, K+S offers the EzyAgric App in Africa, which helps small-scale farmers to improve their harvests thereby raising their standard of living.

Focus on four business segments

K+S's business is focused on four segments: agriculture, industry, consumers, and communities. The same applies in all segments: The customer is the focus of our activities.

K+S - With it's roots in the region, at home all over the world

With roots in the region, at home all over the world. K+S has production sites in Europe and North America, as well as further distribution sites in Africa and Asia.

1 company, 1,000 possibilities: The wide range of career opportunities at K+S

More than 11,000 employees work for us at 50 sites worldwide. Here you will find detailed information about national and international entry and career opportunities.

We care

We strive for sustainability, because we acknowledge our responsibility to the people, the environment, the communities, and the economy in the regions in which we operate.